Quantitative Systematic Strategies’s Tandem Diabetes Care TNDM Stock Holding History

Quantitative Systematic Strategies’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,456	Closed	-$305K	–	657
2021 Q1	$305K	Buy	+3,456	New	+$321K	0.05%	468
2019 Q3	–	Sell	-3,102	Closed	-$200K	–	585
2019 Q2	$200K	Buy	+3,102	New	+$200K	0.04%	413
2019 Q1	–	Sell	-6,470	Closed	-$246K	–	636
2018 Q4	$246K	Buy	+6,470	New	+$228K	0.06%	468
2016 Q3	–	Sell	-1,469	Closed	-$108K	–	489
2016 Q2	$108K	Buy	1,469 +433	+42%	+$34.9K	0.05%	402
2016 Q1	$88K	Sell	1,036 -2,232	-68%	-$195K	0.03%	391
2015 Q4	$378K	Buy	+3,268	New	+$324K	0.1%	251

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Quantitative Systematic Strategies's TNDM Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 3,456 shares — an estimated $305K sold.

Quantitative Systematic Strategies first reported a position in TNDM in Q4 2015 and held it in 6 quarters. The position peaked at $378K in Q4 2015. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Quantitative Systematic Strategies reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 3,456 Tandem Diabetes Care shares in Q2 2021, an estimated $305K.
Quantitative Systematic Strategies first reported a position in Tandem Diabetes Care in Q4 2015 and held it in 6 quarters.
Quantitative Systematic Strategies's Tandem Diabetes Care position peaked at $378K in Q4 2015.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.